LianBio license agreement in which entities affiliated with Perceptive Advisors, LLC hold interests in both the company and LianBio
| Officer | Age | In this role | Joined | 2024 pay | Source |
|---|---|---|---|---|---|
|
Maria Palasis, Ph.D.
Also a director
Principal Executive Officer
Title from the Form 4 dated Apr 1, 2026
|
60 | Not stated | Not stated | $3,732,197 | |
|
Jason Cavalier
Principal Financial Officer
Title from the Form 4 dated Apr 1, 2026
|
Not stated | Not stated | Not stated | $1,303,960 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 4, 2025 · updated by the 8-K of Aug 1, 2025
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
LianBio license agreement in which entities affiliated with Perceptive Advisors, LLC hold interests in both the company and LianBio
Private placement of common stock, pre-funded warrants and accompanying warrants under a Securities Purchase Agreement with the Investors
Ninth Amended and Restated Investor Rights Agreement providing registration rights for these holders' common stock, amended May 25, 2023
Indemnification agreements requiring the company to indemnify each director and executive officer to the fullest extent permitted by Delaware law
Loading...